Kalvista Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The assessment of Kalvista Pharmaceuticals Inc was assembled by All Street Sevva using cutting edge artificial intelligence. Comprehensive Sustainability assessment of Kalvista Pharmaceuticals Inc are reached by registering for free. This article contains a questions and answers table on Kalvista Pharmaceuticals Inc.
Kalvista Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 4.8.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Kalvista Pharmaceuticals Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Kalvista Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Kalvista Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Kalvista Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Kalvista Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Kalvista Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Kalvista Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Kalvista Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.